Data from a meta-analysis presented at the Digestive Disease Week meeting showed positive outcomes from the use of GI Dynamics' EndoBarrier device in patients with type 2 diabetes and obesity. Use of the gut sleeve led to a 1.3% average HbA1c reduction after an average implantation of 8.4 months, as well as an average BMI reduction of 4.2k g/m2 and an average weight loss of 14.2%; HbA1C levels were also maintained at 1% lower than baseline six months after implant removal.
Meta-analysis shows positive results for GI Dynamics' EndoBarrier device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.